Gattefossé

Inertness Compritol® 888 ATO is inert Compritol® 888 ATO - glyceryl dibehenate - does not react with active pharmaceutical ingredients...

  Lipid excipients offer a unique combination of benefits Poor solubility, poor permeability, and pre-systemic elimination are factors that can...

Skin, a gate to drug delivery Many approaches have been developed to overcome the skin barrier properties, including vehicledrug interactions,...

Compritol® 888 ATO: one excipient benefits all, from formulator to end-user Compritol® 888 ATO With a drug release governed by...

Abstract The excipient, Capryol® 90, comprises 90 % monoesters of propylene glycol monocaprylate (C8). With a low hydrophilic lipophilic balance...

Abstract Cancer remains to be one of the most life-threatening diseases with high rates of mortality and morbidity. The major...

Abstract Lipid-based formulations (LBFs) play a crucial role in enhancing the oral bioavailability of poorly water-soluble drugs by leveraging lipid...

Abstract Background: Centaurium erythraea Rafn. (C. erythraea) is a medicinal plant traditionally used in European folk medicine for the treatment of...

The new webinar by our partner Gattefossé: This webinar will explore how Self-Emulsifying Drug Delivery Systems (SEDDS) and other lipid-based...

Abstract The liquid and solid formulations of self-nano-emulsifying drug delivery systems (SNEDDS) have garnered significant attention in the pharmaceutical field...